Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/20663
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEstrada, Ernesto-
dc.contributor.authorPatlewicz, Grace-
dc.contributor.authorUriarte, Eugenio-
dc.date.accessioned2013-08-20T09:35:11Z-
dc.date.available2013-08-20T09:35:11Z-
dc.date.issued2003-06-
dc.identifier.issn0975-0975(Online); 0376-4710(Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/20663-
dc.description1315-1329en_US
dc.description.abstractA review on the use of topological indices (TIs) in the process of drug design and development is presented on the basis of the most recent advances in this field. The first part of this work is focussed on introducing the definitions of terms used in drug design and discovery, graph-theoretical chemistry as well as topological indices. The second part of the review discusses the use of topological indices in the lead discovery and optimization processes, including similarity/dissimilarity studies, rational combinatorial library design, QSAR, the issue of 2D versus 3D QSAR, as well as the use of novel chemometric techniques, such as artificial neural networks, genetic algorithms and partial least squares in combination with TIs. Recent advances on the definition of TIs accounting for three dimensional molecular features (topographic indices) and molecular chirality are also presented.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJC-A Vol.42A(06) [June 2003]en_US
dc.titleFrom molecular graphs to drugs. A review on the use of topological indices in drug design and discoveryen_US
dc.typeArticleen_US
Appears in Collections:IJC-A Vol.42A(06) [June 2003]

Files in This Item:
File Description SizeFormat 
IJCA 42A(6) 1315-1329.pdf3.97 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.